Sodium–glucose cotransporter 2 inhibitor‐induced euglycaemic diabetic ketoacidosis in heart failure with preserved ejection fraction

The number of patients receiving sodium–glucose cotransporter 2 inhibitors (SGLT2is), especially those with heart failure, is increasing worldwide. SGLT2is control glycaemia by triggering glycosuria with simultaneous facilitation of a more ketogenic metabolic profile. Patients therefore are more pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Cavka, Luka, Bencak Ferko, Urska, Pitz, Natasa, Trpkovski, Zoranco, Lainscak, Mitja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318418/
https://www.ncbi.nlm.nih.gov/pubmed/34102028
http://dx.doi.org/10.1002/ehf2.13452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318418/
https://www.ncbi.nlm.nih.gov/pubmed/34102028
http://dx.doi.org/10.1002/ehf2.13452

Ejemplares similares